Surgery Partners, Inc. (SGRY)
USD 23.08
(2.9%)
USD 23.08
(2.9%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.01 Billion USD | 5.04% |
| 2022 | 6.68 Billion USD | 9.23% |
| 2021 | 6.11 Billion USD | 13.01% |
| 2020 | 5.41 Billion USD | 7.85% |
| 2019 | 5.01 Billion USD | 7.34% |
| 2018 | 4.67 Billion USD | 1.16% |
| 2017 | 4.62 Billion USD | 100.56% |
| 2016 | 2.3 Billion USD | 9.41% |
| 2015 | 2.1 Billion USD | 13.34% |
| 2014 | 1.85 Billion USD | 291.57% |
| 2013 | 474.7 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.97 Billion USD | -0.62% |
| 2024 Q2 | 7.48 Billion USD | 7.35% |
| 2023 Q2 | 6.62 Billion USD | -0.34% |
| 2023 Q1 | 6.64 Billion USD | -0.58% |
| 2023 Q3 | 6.78 Billion USD | 2.41% |
| 2023 FY | 7.01 Billion USD | 5.04% |
| 2023 Q4 | 7.01 Billion USD | 3.53% |
| 2022 Q4 | 6.68 Billion USD | 2.23% |
| 2022 FY | 6.68 Billion USD | 9.23% |
| 2022 Q1 | 6.28 Billion USD | 2.81% |
| 2022 Q2 | 6.29 Billion USD | 0.03% |
| 2022 Q3 | 6.53 Billion USD | 3.89% |
| 2021 Q2 | 5.62 Billion USD | -0.33% |
| 2021 Q1 | 5.63 Billion USD | 4.17% |
| 2021 FY | 6.11 Billion USD | 13.01% |
| 2021 Q4 | 6.11 Billion USD | 8.63% |
| 2021 Q3 | 5.63 Billion USD | 0.2% |
| 2020 FY | 5.41 Billion USD | 7.85% |
| 2020 Q3 | 5.31 Billion USD | 1.3% |
| 2020 Q4 | 5.41 Billion USD | 1.89% |
| 2020 Q2 | 5.24 Billion USD | 3.02% |
| 2020 Q1 | 5.09 Billion USD | 1.42% |
| 2019 Q4 | 5.01 Billion USD | 2.07% |
| 2019 FY | 5.01 Billion USD | 7.34% |
| 2019 Q3 | 4.91 Billion USD | 0.54% |
| 2019 Q2 | 4.89 Billion USD | 0.2% |
| 2019 Q1 | 4.88 Billion USD | 4.38% |
| 2018 Q4 | 4.67 Billion USD | 2.58% |
| 2018 FY | 4.67 Billion USD | 1.16% |
| 2018 Q1 | 4.59 Billion USD | -0.6% |
| 2018 Q2 | 4.58 Billion USD | -0.24% |
| 2018 Q3 | 4.55 Billion USD | -0.55% |
| 2017 Q3 | 4.6 Billion USD | 72.26% |
| 2017 Q4 | 4.62 Billion USD | 0.45% |
| 2017 FY | 4.62 Billion USD | 100.56% |
| 2017 Q1 | 2.28 Billion USD | -0.66% |
| 2017 Q2 | 2.67 Billion USD | 16.67% |
| 2016 Q3 | 2.24 Billion USD | 1.59% |
| 2016 FY | 2.3 Billion USD | 9.41% |
| 2016 Q4 | 2.3 Billion USD | 2.5% |
| 2016 Q2 | 2.21 Billion USD | 0.51% |
| 2016 Q1 | 2.2 Billion USD | 4.54% |
| 2015 Q4 | 2.1 Billion USD | 11.38% |
| 2015 Q2 | 1.84 Billion USD | -0.13% |
| 2015 FY | 2.1 Billion USD | 13.34% |
| 2015 Q3 | 1.89 Billion USD | 2.35% |
| 2015 Q1 | 1.85 Billion USD | -0.45% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | 1.85 Billion USD | 291.57% |
| 2014 Q4 | 1.85 Billion USD | 0.0% |
| 2013 FY | 474.7 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | -30.982% |
| Addus HomeCare Corporation | 1.02 Billion USD | -585.174% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | -3186.834% |
| Amedisys, Inc. | 2.06 Billion USD | -240.705% |
| Astrana Health, Inc. | 933.36 Million USD | -652.024% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | -328.736% |
| IMAC Holdings, Inc. | 1.14 Million USD | -613393.876% |
| biote Corp. | 155.29 Million USD | -4419.849% |
| Cryo-Cell International, Inc. | 61.22 Million USD | -11365.227% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | -933.258% |
| COMPASS Pathways plc | 275.98 Million USD | -2443.272% |
| DocGo Inc. | 490.45 Million USD | -1331.149% |
| The Ensign Group, Inc. | 4.17 Billion USD | -68.02% |
| Healthcare Services Group, Inc. | 803.18 Million USD | -773.912% |
| InnovAge Holding Corp. | 547.66 Million USD | -1181.651% |
| The Joint Corp. | 87.15 Million USD | -7953.965% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | -214.306% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -88183.737% |
| ModivCare Inc. | 1.76 Billion USD | -297.171% |
| NewGenIvf Group Limited | 1.64 Million USD | -425955.868% |
| Option Care Health, Inc. | 3.32 Billion USD | -110.888% |
| P3 Health Partners Inc. | 860.96 Million USD | -715.258% |
| P3 Health Partners Inc. | 860.96 Million USD | -715.258% |
| The Pennant Group, Inc. | 539.69 Million USD | -1200.578% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -142469.501% |
| Talkspace, Inc. | 142.22 Million USD | -4835.347% |
| Talkspace, Inc. | 142.22 Million USD | -4835.347% |
| The Oncology Institute, Inc. | 219.41 Million USD | -3098.963% |
| The Oncology Institute, Inc. | 219.41 Million USD | -3098.963% |